Shire Strategic Investment Group Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
8
- Exits
-
5
Shire Strategic Investment Group General Information
Company Description
Shire Strategic Investment Group was Shire's corporate venture fund, tasked with identifying and investing in external innovation that may bring new products to Shire's pipeline and which support Shire's mission to enable people with life-altering conditions to lead better lives. Further to that mission, Shire was focused on delivering novel, cost-effective therapies to patients with symptomatic diseases and significant unmet medical need. Accordingly, the SIG sought to invest across a broad range of therapeutic areas of interest including central nervous system/neuropsychiatry, gastrointestinal, orphan genetic diseases, allergy, and hematology.
Business Details
Year Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 725 Chesterbrook Boulevard
- Wayne, PA 19087
- United States
Shire Strategic Investment Group Investments (8)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Aptinyx | 15-Sep-2015 | Seed Round | Drug Discovery | Bankruptcy: Liquidation | ||
| Proclara Biosciences | 06-May-2013 | Drug Discovery | Out of Business | |||
| Naurex | 17-Dec-2012 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Promedior | 15-Oct-2012 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Proclara Biosciences | 08-Mar-2012 | Drug Discovery | Out of Business | |||
| Naurex | 11-May-2011 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Prexa Pharmaceuticals | 11-May-2011 | Early Stage VC | Pharmaceuticals | Out of Business | ||
| Proclara Biosciences | 01-Mar-2011 | Later Stage VC | Drug Discovery | Out of Business |
Shire Strategic Investment Group Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Promedior | 13-Feb-2020 | Merger/Acquisition | |
| Proclara Biosciences | 31-Jul-2019 | ||
| Aptinyx | 21-Jun-2018 | ||
| Naurex | 28-Aug-2015 | Merger/Acquisition | |
| Prexa Pharmaceuticals | 01-May-2015 | Out of Business |
Shire Strategic Investment Group Investments by Industry, Year, and Region
Shire Strategic Investment Group FAQs
-
What is Shire Strategic Investment Group?
Shire Strategic Investment Group was Shire's corporate venture fund, tasked with identifying and investing in external innovation that may bring new products to Shire's pipeline and which support Shire's mission to enable people with life-altering conditions to lead better lives.
-
When was Shire Strategic Investment Group founded?
Shire Strategic Investment Group was founded in 2011.
-
Where is Shire Strategic Investment Group headquartered?
Shire Strategic Investment Group is headquartered in Wayne, PA.
-
How many investments has Shire Strategic Investment Group made?
Shire Strategic Investment Group has made 8 investments.
-
What has Shire Strategic Investment Group invested in?
Shire Strategic Investment Group has made numerous investments in companies like Aptinyx, Proclara Biosciences, and Naurex within the Drug Discovery industry.
-
What has Shire Strategic Investment Group invested in recently?
Shire Strategic Investment Group's latest investment was on 15-Sep-2015 in Aptinyx, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process